New research by investigators in Ghent, Belgium shows that intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be an effective strategy in fighting antimicrobial resistance. The findings are presented at ASM Microbe 2023, the annual meeting of the American Society for Microbiology.
Intravenous treatment with MK-3402 can be an effective strategy in fighting antimicrobial resistance
- Thread starter Educator
- Start date